YOLFTbeta
30

INKON Life Technology Co Ltd

300143 · SHE · Healthcare / Medical Devices

7.06CNY-0.18 (-2.49%)

Price History

Full chart

Market Stats

Previous Close7.24
Open7.22
Day Range7.04 – 7.25
52-Week Range6.40 – 11.03
Volume6.32M
Market Cap7.64B
P/E (TTM)112.14
Forward P/E54.35
EPS0.07
Dividend Yield0.32%
Beta0.29
50-Day Avg7.60
200-Day Avg8.26

About

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Qingdao, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. An Jie Ma
  • Employees2.66K
  • HeadquartersYingkang Yisheng Building, Qingdao, China, 266103, China
  • Websitehttps://www.inkonlife.com

Leadership

  • Mr. An Jie MaGM & Director · b. 1980
  • Ms. Lan JiangFinancial Director · b. 1981
  • Mr. Zelin LiuBoard Secretary · b. 1993
  • Mr. Hongbo LiDeputy General Manager · b. 1971
  • Jinchen XieAccounting Supervisor

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue60.51M73.89M95.77M167.93M207.57M247.83M254.84M307.54M280.14M432.45M329.23M504.02M572.94M661.05M1.09B1.16B1.47B1.56B1.89B
Growth (%)-+22.12%+29.61%+75.35%+23.60%+19.40%+2.83%+20.68%-8.91%+54.37%-23.87%+53.09%+13.67%+15.38%+64.87%+6.09%+27.20%+6.01%+20.93%
Cost of Revenue36.71M38.81M45.83M76.76M105.40M151.39M185.69M224.43M199.74M258.49M141.91M274.95M343.54M438.27M829.00M849.46M1.05B1.16B1.37B
Gross Profit--------80.40M173.96M187.32M229.08M229.40M222.79M260.87M306.78M415.89M403.28M510.93M
Gross Margin--------28.70%40.23%56.90%45.45%40.04%33.70%23.94%26.53%28.28%25.86%27.10%
Operating Expense--------66.88M110.14M70.74M101.86M130.09M138.82M184.40M187.34M249.53M246.11M279.56M
Operating Income11.11M13.37M21.13M41.22M32.64M---13.52M63.83M116.59M127.22M99.31M83.96M76.47M119.45M166.36M157.17M231.36M
Operating Margin18.37%18.10%22.06%24.55%15.73%---4.83%14.76%35.41%25.24%17.33%12.70%7.02%10.33%11.31%10.08%12.27%
EBITDA----------194.97M145.38M-587.23M226.68M-248.47M-501.37M215.36M250.27M280.44M
EBITDA Margin----------59.22%28.84%-102.50%34.29%-22.80%-43.36%14.64%16.05%14.87%
Net Income9.94M11.46M20.35M42.20M58.85M6.49M--10.58M55.08M122.40M50.17M-703.41M128.11M-364.08M-595.92M100.44M115.42M68.54M
Net Income Margin16.43%15.51%21.25%25.13%28.35%2.62%--3.78%12.74%37.18%9.95%-122.77%19.38%-33.41%-51.54%6.83%7.40%3.64%
R&D-------6.45M7.03M14.19M7.03M7.25M11.02M17.00M28.86M28.03M52.24M54.52M49.19M
R&D as % of Total Revenue-------2.10%2.51%3.28%2.14%1.44%1.92%2.57%2.65%2.42%3.55%3.50%2.61%
Interest Expense000000000008.36M30.83M19.61M17.37M8.15M7.58M11.94M19.66M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.66%5.38%2.97%1.59%0.70%0.52%0.77%1.04%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets140.23M164.27M224.64M851.32M830.26M999.85M1.03B804.00M1.85B2.53B2.61B2.62B1.96B2.65B2.47B2.03B2.40B3.54B4.19B
Total Liabilities65.34M82.72M107.73M124.32M44.42M189.08M391.00M460.03M364.75M338.19M178.45M555.28M589.67M410.10M667.57M710.51M971.42M1.06B1.58B
Total Equity74.89M81.55M116.90M727.00M785.85M762.86M599.70M306.43M1.44B2.16B2.38B2.04B1.34B2.21B1.77B1.28B1.38B2.43B2.51B
Cash2.54M3.46M22.59M565.57M341.17M52.49M33.89M61.04M108.51M212.68M245.36M93.98M96.55M483.64M661.55M433.18M480.49M1.24B1.07B
Net Debt-----------256.02M233.45M------

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow32.02M20.24M25.54M61.51M91.32M27.06M13.60M21.25M52.37M44.62M166.82M99.69M29.78M84.77M125.61M160.67M190.01M259.25M340.83M
Investing Cash Flow--------118.62M-544.04M-192.24M-614.66M-13.73M-207.86M229.95M-409.76M---
Financing Cash Flow27.66M48.00K40.93M585.71M-74.56M124.37M46.39M-123.52M603.57M59.08M363.29M-13.68M497.21M-210.52M20.34M---
Capital Expenditure58.06M23.97M50.56M104.25M226.69M392.33M156.43M52.48M31.91M28.09M61.72M25.31M26.91M62.82M56.33M125.38M158.20M198.67M226.64M
Free Cash Flow----------105.10M74.38M2.87M35.44M69.29M35.29M31.81M60.58M114.19M
Dividends Paid3.32M4.62M8.11M4.89M632.00K31.49M15.45M20.16M17.67M17.92M7.43M7.43M30.11M19.68M6.75M27.67M1.26M8.62M10.48M
FCF to OCF----------63.00%74.61%9.62%41.81%55.16%21.96%16.74%23.37%33.50%
Dividend Paid to FCF----------7.07%10.00%1050.65%55.51%9.74%78.41%3.95%14.22%9.17%

Earnings

Report DateAug 24, 2014Oct 23, 2014Dec 31, 2014Apr 23, 2015Jul 17, 2015Oct 22, 2015Feb 26, 2016Apr 21, 2016Aug 12, 2016Oct 24, 2016Feb 27, 2017Apr 26, 2017Aug 17, 2017Oct 22, 2017Mar 16, 2018Apr 26, 2018Aug 24, 2018Oct 22, 2018Dec 31, 2018Apr 26, 2019Aug 25, 2019Oct 29, 2019Dec 31, 2019Apr 29, 2020Aug 28, 2020Oct 29, 2020Dec 31, 2020Apr 27, 2021Aug 26, 2021Oct 28, 2021Dec 31, 2021Apr 28, 2022Aug 23, 2022Oct 26, 2022Mar 29, 2023Apr 27, 2023Aug 29, 2023Oct 26, 2023Feb 23, 2024Apr 25, 2024Jun 30, 2024Oct 27, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------
EPS Actual-0.06-0.06-0.720.000.020.010.000.020.010.030.040.090.060.08-0.010.070.020.04-0.020.000.040.03-1.05-0.020.070.030.100.020.020.12-0.590.040.040.01-1.480.060.050.040.010.040.030.040.040.040.030.03-0.020.030.04
Surprise-------------------------------------------------
TimingAfter-hoursAfter-hours-Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap7.64B
Enterprise Value7.22B
Trailing P/E112.14
Forward P/E54.35
PEG Ratio0.00
Price / Sales3.71
Price / Book3.20
EPS0.07
Book Value2.47
Revenue (TTM)2.06B
Gross Profit (TTM)568.54M
EBITDA287.37M
Profit Margin3.60%
Operating Margin14.24%
Return on Equity4.29%
Return on Assets3.55%
Shares Outstanding972.93M
Shares Float468.79M
Beta0.29
Dividend Yield0.32%
Dividend Rate0.03
Payout Ratio32.64%

Dividends

20261×
0.03Jun 3, 2026
20121×
0.08Mar 30, 2012

Stock Splits

  • Jun 3, 20261.3:1
  • Apr 25, 20181.9:1
  • Mar 25, 201122:10